Synthesis of 1-Aryl-1H-indazoles via Intramolecular Amination Reaction
(t, J=7.6 Hz, 1H), 2.67 (s, 3H); ESI-MS m/z: 208.7 [M
+H]+.
Iwasaki, T. Arzneim. Forsch. 1979, 29, 511.
3
(a) Sun, J.-H.; Teleha, C. A.; Yan, J.-S.; Rodgers, J. D.;
Nugiel, D. A. J. Org. Chem. 1997, 62, 5627.
3-Phenethyl-1-phenyl-1H-indazole (8k)
Pale
1
yellow oil; H NMR (CDCl3, 400 MHz) δ: 7.74 (d, J=
8.4 Hz, 3H), 7.70 (d, J=8.0 Hz, 1H), 7.54 (t, J=7.6 Hz,
2H), 7.44— 7.30 (m, 6H), 7.26— 7.18 (m, 2H),
3.39— 3.35 (m, 2H), 3.24— 3.20 (m, 2H); 13C NMR
(CDCl3, 100 MHz) δ: 147.23, 141.77, 140.31, 139.50,
129.40, 128.49, 128.43, 127.06, 126.19, 126.05, 124.31,
122.54, 120.84, 120+.52, 110.40,35.39, 29.18; ESI-MS
m/z: 299.1 [M+H] ; HRMS (ESI) calcd for C21H18N2
[M+H]+ 298.1453, found 299.1542.
(b) Rodgers, J. D.; Johnson, B. L.; Wang, H.; Greenberg, R.
A.; Erickson-Viitanen, S.; Klabe, R. M.; Cordova, B. C.;
Rayner, M. M.; Lam, G. N.; Chang, C.-H. Bioorg. Med.
Chem. Lett. 1996, 6, 2919.
4
(a) Bistochi, G. A.; De Meo, G.; Pedini, M.; Ricci, A.;
Brouilhet, H.; Bucherie, S.; Rabaud, M.; Jacquignon, P.
Farmaco Ed. Sci. 1981, 36, 315.
(b) Picciola, G.; Ravenna, F.; Carenini, G.; Gentili, P.; Riva,
M. Farmaco Ed. Sci. 1981, 36, 1037.
1-Phenyl-1H-pyrazolo[3,4-b]pyridine (9a) White
5
6
Corsi, G.; Palazzo, G.; Germani, C.; Barcellona, P. S.;
Silvestrini, B. J. Med. Chem. 1976, 19, 778.
1
solid, m.p. 53— 55 ℃ (lit.14 53 ℃); H NMR (CDCl3,
400 MHz) δ: 8.63 (dd, J=4.8, 1.6 Hz, 1H), 8.29 (d, J=
7.2 Hz, 2H), 8.12 (s, 1H), 8.10 (dd, J=7.2, 1.6 Hz, 1H),
7.56 (t, J=7.2 Hz, 2H), 7.32 (t, J=6.4 Hz, 1H), 7.+21
(dd, J=8.4, 4.8 Hz, 1H); ESI-MS m/z: 196.1 [M+H] .
1-(4-Chlorphenyl)-1H-pyrazolo[3,4-b]pyridine (9b)
For reviews, see: (a) Elguero, J. In Comprehensive
Heterocyclic Chemistry, Vol 5, Eds.: Karizky, A. R.; Rees,
C. W., Pergamon Press, New York, 1984, p. 167.
(b) Behr, L. C.; Fusco, R.; Jarobe, C. H. In Pyrazoles,
Pyrazonlines, Pyrazolidines, Indazoles and Condensed
Rings, R. H. Wiley Int, New York, 1969, p. 28.
(a) Paal, C. Chem. Ber. 1891, 24, 959.
1
White solid, m.p. 100—101 ℃; H NMR (CDCl3, 400
MHz) δ: 8.63 (dd, J=4.4, 1.6 Hz, 1H), 8.31 (dt, J=8.8,
2.8 Hz, 2H), 8.20 (s, 1H), 8.15 (dd, J=8.0, 1.6 Hz, 1H),
7.51 (dt, J=8.8, 2.8 Hz, 2H), 7.25 (dd, J=8.0, 4.4 Hz,
1H); 13C NMR (CDCl3, 100 MHz) δ: 150.13, 149.23,
138.12, 134.12, 131.34, 130.30, 129.15, 122.18, 117.81,
117.32; ESI-MS m/z (%): 230.0 ([M+H]+, 100), 232.0
([M+3]+, 32.1); HRMS (ESI) calcd for C12H8ClN3
[M+H]+ 230.0480, found 230.0484.
7
8
(b) Campi, E. M.; Habsuda, J.; Jackson, W. R.; Jonasson, C.
A. M.; McCubbin, Q. Aust. J. Chem. 1995, 48, 2023.
(c) Frontana-Uribe, B. A.; Moinet, C. Tetrahedron 1998, 54,
3197.
(a) Lebedev, A. Y.; Khartulyari, A. S.; Voskoboynikov, A.
Z. J. Org. Chem. 2005, 70, 596.
(b) Song, J. J.; Yee, N. K. Tetrahedron Lett. 2001, 42, 2937.
(c) Wolfe, J. P.; Wagaw, S.; Marcoux, J.-F.; Buchwald, S. L.
Acc. Chem. Res. 1998, 31, 805.
1-Phenyl-1-H-furo[3,2-c]pyrazole (9c)
White
1
solid, m.p. 39— 40 ℃; H NMR (CDCl3, 400 MHz) δ:
7.65 (d, J=2.0 Hz, 2H), 7.52 (s, 1H), 7.48 (d, J=2.4
Hz, 1H), 7.38 (t, J=2.4 Hz, 2H), 7.15 (t, J=2.4 Hz,
1H), 6.67 (d, J=2.0 Hz, 1H); 13C NMR (CDCl3, 100
MHz) δ: 150.28, 148.83, 140.36, 135.02, 129.45, 125.42,
121.05, 117.74, 99.36; ESI-MS m/z: 185.0 [M+H]+;
HRMS (ESI) calcd for C11H8N2O [M+H]+ 185.0797,
found 185.0713.
(d) Hartwig, J. F. Angew. Chem., Int. Ed. 1998, 37, 2046.
(a) Caron, S.; Vazquez, E. Synthesis 1999, 4, 588.
(b) Cui, J. J.; Araldi, G.-L.; Reiner, J. E.; Reddy, K. M.;
Kemp, S. J.; Ho, J. Z.; Siev, D. V.; Mamedova, L.; Gibson,
T. S.; Gaudette, J. A.; Minami, N. K.; Anderson, S.;
Bradbury, A. E.; Nolan, T. G.; Semple, J. E. Bioorg. Med.
Chem. Lett. 2002, 12, 2925.
9
3-Methyl-1-phenyl-1H-thieno[3, 2-c]pyrazole (9d)
Black soild, m.p. 45— 47 ℃ (lit.15 46—47 ℃); 1H NMR
(CDCl3, 400 MHz) δ: 7.77 (d, J = 2.0 Hz, 2H),
7.54— 7.48 (m, 3H), 7.31— 7.25 (m, 2H), 2.57 (s, 3H);
ESI-MS m/z: 215.1 [M+H]+.
(c) Dehmlow, H.; Aebi, J. D.; Jolidon, S.; Ji, Y.-H.; Mark, E.
M.; Himer, J.; Morand, O. H. J. Med. Chem. 2003, 46,
3354.
10 For recent reviews about copper-catalysed Ullmann-type
coupling reactions, see: (a) Ley, S. V.; Thomas, A. W.
Angew. Chem., Int. Ed. 2003, 42, 5400.
5-Chloro-3-methyl-1-phenyl-1H-thieno[2,3-c]pyra-
zole (9e) White solid, m.p. 53—54 ℃; 1H NMR
(CDCl3, 400 MHz) δ: 7.67 (d, J=8.8 Hz, 2H), 7.48 (t,
J=8.8 Hz, 2H), 7.27— 7.23 (m, 1H), 6.93 (s, 1H), 2.50
(s, 3H); 13C NMR (CDCl3, 100 MHz) δ: 142.27, 139.33,
137.98, 129.61, 127.68, 125.47, 117.45, 115.05, 13.02;
ESI-MS m/z (%): 249.9 ( [M+H]+, 100), 251.9 ([M+
3]+, 36.5); HRMS (ESI) calcd for C12H9ClN2S [M+
H]+ 249.0248, found 249.0248.
(b) Beletskaya, I. P.; Cheprakov, A. V. Coord. Chem. Rev.
2004, 248, 2337.
(c) Lindley, J. Tetrahedron 1984, 40, 1433.
(d) Evano, G.; Blanchard, N.; Toumi, M. Angew. Chem., Int.
Ed. 2009, 48, 6954.
11 (a) Pabba, C.; Wang, H.; Mulligan, S. R.; Chen, Z.; Stark, T.
M.; Gregg, B. T. Tetrahedron Lett. 2005, 46, 7553.
(b) Vina, D.; Olmo, E.; Lopez-Perez, J. L.; Feliciano, A. S.
Org. Lett. 2007, 9, 525.
References
(c) Liu, R.; Zhu, Y.; Qin, L.; Ji, S. Synth. Commun. 2008, 38,
249.
1
Keppler, B. K.; Hartmann, M. Met.-Based Drugs 1994, 1,
145.
12 For some recent examples, see: (a) Liu, X.; Fu, H.; Jiang, Y.;
Zhao, Y. Angew. Chem., Int. Ed. 2009, 48, 348.
(b) Yang, D.; Fu, H.; Hu, L.; Jiang, Y.; Zhao, Y. J. Org.
2
Ykeda, Y.; Takano, N.; Matsushita, H.; Shiraki, Y.; Koide,
T.; Nagashima, R.; Fujimura, Y.; Shindo, M.; Suzuki, S.;
Chin. J. Chem. 2011, 29, 1199— 1204
© 2011 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1203